Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
153M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
5.12M
-
Shares change
-
+904K
-
Total reported value, excl. options
-
$67.6M
-
Value change
-
+$8.67M
-
Number of buys
-
34
-
Number of sells
-
-13
-
Price
-
$13.21
Significant Holders of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) as of Q2 2021
51 filings reported holding BDSX - BIODESIX INC - Common Stock, par value $0.001 per share as of Q2 2021.
BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.12M shares
of 153M outstanding shares and own 3.34% of the company stock.
Largest 10 shareholders include Birchview Capital, LP (1.1M shares), BlackRock Inc. (574K shares), KORNITZER CAPITAL MANAGEMENT INC /KS (438K shares), Asymmetry Capital Management, L.P. (381K shares), VANGUARD GROUP INC (364K shares), ORACLE INVESTMENT MANAGEMENT INC (236K shares), Parian Global Management LP (219K shares), CANNELL PETER B & CO INC (206K shares), GEODE CAPITAL MANAGEMENT, LLC (146K shares), and FRED ALGER MANAGEMENT, LLC (137K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.